Lord, Abbett & Co
ABVX

Lord, Abbett & Co’s Abivax ABVX Stock Holding History

Lord, Abbett & Co’s Portfolio ABVX Stock Details ABVX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.27M Sell
9,500
-845,420
-99% -$95.7M ﹤0.01% 538
2026
Q1 		$95.2M Buy
854,920
+5,188
+0.6% +$614K 0.31% 85
2025
Q4 		$115M Buy
849,732
+513,026
+152% +$56M 0.35% 77
2025
Q3 		$28.6M Buy
+336,706
New +$20.6M 0.09% 239

Other funds holding ABVX

TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
HI
Helikon Investments London, United Kingdom $3.35B AUM 55.08% 1-Year Est. Return
DGM
Darwin Global Management St. Helier, Jersey $3.76B AUM 342.13% 1-Year Est. Return
VPC
Vestal Point Capital New York $4.28B AUM 239% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $2.19B AUM 374.99% 1-Year Est. Return
CP
Caligan Partners New York $2.13B AUM 758.65% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Lord, Abbett & Co's ABVX Position: Q2 2026 in Review

Lord, Abbett & Co reduced its Abivax (ABVX) stake by 99% in Q2 2026, selling an estimated $95.7M and leaving 9,500 shares worth $1.27M. The position accounts for ﹤0.01% of the portfolio, ranked #538.

Lord, Abbett & Co first reported a position in ABVX in Q3 2025 and has held it in 4 quarters since. The position peaked at $115M in Q4 2025. 302 funds tracked by Wall St. Rank hold ABVX as of Q2 2026.

  • Lord, Abbett & Co held 9,500 shares of Abivax worth $1.27M as of Q2 2026.
  • Lord, Abbett & Co sold 845,420 Abivax shares in Q2 2026, an estimated $95.7M.
  • Abivax made up ﹤0.01% of Lord, Abbett & Co's portfolio in Q2 2026, its #538 holding.
  • Lord, Abbett & Co first reported a position in Abivax in Q3 2025 and has held it in 4 quarters since.
  • Lord, Abbett & Co's Abivax position peaked at $115M in Q4 2025.
  • 302 funds tracked by Wall St. Rank held Abivax as of Q2 2026.

Based on Lord, Abbett & Co's 13F filing for Q2 2026, filed 14 Aug 2026.